Second Year, D.Pharmacy Important Question
BP-204/8109, ER20-24T
Pharmacotherapeutics,
II Year, RGPV, D.Pharmacy
Chapter 1 Pharmacotherapeutics
Q.1 Write the common problems faced by patients in drug use. (RGPV 2025)
Q.2 Classify Evidence Based Medicines. (RGPV 2025)
Q.3 Write notes on (RGPV 2025)
a) Standard Treatment Guidelines (STG)
b) Rational use of medicines
Q.4 Define Evidence Based Medicines. Write the steps involved in Evidence Based Medicines. (RGPV 2024)
Q.5 Explain Standard Treatment Guidelines (STG), Write the advantages of STG to patients and Health Care Workers. (RGPV 2024)
Q.6 Explain Essential drugs and Essentials Drug list. (RGPV 2023)
Q.7 Discuss the factors resulting m ivational use of drugs. (RGPV 2023)
Q.8 Explain the barrier’s to Medication Adherence. (RGPV 2023)
Chapter 2 Definition, Etiopathogenesis, clinical manifestations, non pharmacological and pharmacological management of the diseases associated with
Q.1 Write the non pharmacological treatment of the following- (RGPV 2025)
a) Hypertension
b) Type II Diabetes
c) Covid 19
d) Psychosis
Q.2 Write the etiopathogenesis and symptoms of Hypertension or Congestive heart failure. (RGPV 2024)
Q.3 Write the signs and symptoms of Immuno-Suppression. (RGPV 2024)
(a) Cardiovascular System
Q.1 Write the causes of Hypertension. (RGPV 2025)
Q.2 Write the symptoms of Hyperlipidemia. (RGPV 2025)
Q.3 Discuss the pathophysiology and treatment of Myocardial Infarction. (RGPV 2025)
Q.4 Write the pharmacological and non-pharmacological treatment of Angina pectoris. (RGPV 2023)
(b) Respiratory System
Q.1 Write the risk factors for Asthma. (RGPV 2025)
Q.2 Write the causes and treatment of COPD. (RGPV 2025)
Q.3 Write the pharmacological treatment of COPD. (RGPV 2024)
Q.4 Write the factors that stimul Asthma. (RGPV 2023)
Q.5 Write the pharmacological and non-pharmacological treatment of Asthma. (RGPV 2023)
(c) Endocrine System
Q.1 Explain the pathophysiology of Hypothyroidism. (RGPV 2025)
Q.2 Write the etiopathogenesis and risk factors for type 2 diabetes. (RGPV 2024)
Q.3 Write a note on Hypothyroidism disorders. (RGPV 2024)
(d) Central Nervous System
Q.1 Explain the pharmacological treatment of Migraine. (RGPV 2025)
Q.2 Write the causes of Stroke. (RGPV 2025)
Q.3 Write the pharmacological treatment of the Epilepsy. (RGPV 2025)
Q.4 Write a note on any two. (RGPV 2024)
a) Migraine
b) Epilepsy
c) Parkinson’s disease
d) Alzheimer’s disease
(e) Gastro Intestinal Disorders
Q.1 Describe the causes and pharmacological treatment of GERD of Peptic Ulcer disease. (RGPV 2024)
(f) Haematological disorders
Q.1 Discuss different types of anemia. (RGPV 2025)
Q.2 Discuss the pathophysiology of megaloblastic Anemia. (RGPV 2024)
Q.3 Write the pharmacological and non-pharmacological treatment of Iron Deficiency anaemia. (RGPV 2023)
(g) Infectious diseases
Q.1 Write a note on GERD or Hepatitis. (RGPV 2025)
Q.2 Write the risk factors for UTI. (RGPV 2025)
Q.3 Write the pharmacological treatment of the AIDS (RGPV 2025)
Q.4 Write the diagnostic tests for the following. (any two) (RGPV 2024)
i) Tuberculosis
ii) Pneumonia
iii) Urinary tract infection
Q.5 Discuss the life-cycle of Malarial parasite. (RGPV 2024)
Q.6 Write a note on Respiratory viral infections. (RGPV 2023)
Q.7 Discuss the opportunistic infections in HIV. (RGPV 2023)
Q.8 Write a note on Hepatitis. (RGPV 2023)
Q.9 Explain the types of Tuberculosis, Discuss the causes of drug resistance in Tuberculous (RGPV 2023)
Q.10 Write the causes of Urinary tract infections (RGPV 2023)
Q.11 Write the pharmacological and non-pharmacological treatment of SARS. (RGPV 2023)
(h) Musculoskeletal disorders
Q.1 Write the causes and symptoms of Rheumatoid Arthritis. (RGPV 2023)
(j) Psychiatric Disorders
Q.1 Write notes on (any two) (RGPV 2024)
a) Osteoarthritis
b) Psoriasis
c) Conjunctivitis
d) Depression
Q.2 Write notes on Psychotic Disorders. (RGPV 2023)
Q.3 Write the pharmacological and non-pharmacological treatment of Depression. (RGPV 2023)
(k) Ophthalmology
Q.1 Give the etiopathogenesis and Clinical manifestations of Conjunctivitis (RGPV 2025)
Q.2 Write notes on Glaucoma. (RGPV 2023)
(l) Anti-microbial Resistance
Q.1 Write a detailed note on Antimicrobial Resistance. (RGPV 2025)
Q.2 Explain Antimicrobial resistance with examples. Discuss the mechanism of Antimicrobial resistance. (RGPV 2024)
Q.3 Write notes on Anti Microbial Resistance. (RGPV 2023)
(m) Women’s Health
Q.1 Write notes on Polycystic Ovary Syndrome (RGPV 2023)
Choose the correct answer
Q.1 Oral medications are not used for- (RGPV 2025)
(a). Type I diabetes
(Type II diabetes
(c) Both (a) and (b)
(d) None
Q.2 The nonpharmacological treatment for Thyroid disease is- (RGPV 2025)
(a) Yoga
(b) Meditation
(c) lodine rich diet
(d) All the above
Q.3 The disease in which multiple drug resistance is common (RGPV 2025)
(a) Tuberculosis
(b) Amoebiasis
(c) Covid 19
(4) All the above
Q.4 The pharmacological treatment for Hypertension includes: (RGPV 2025)
(a) Beta blockers
(b) ACE Inhibitors
(c) Vasodilators
(d) All the above
Q.5 The clinical manifestations of PMS include- (RGPV 2025)
(a) Food Cravings
(b) Social withdrawal
(c) Mood changes
(d) All the above
Fill in the Blanks
Q.1 The normal value of Blood Cholesterol level is………………(RGPV 2025)
Q.2The Alzheimer’s disease is a…………………………….. disease. (RGPV 2025)
Q.3 The HDL is also known as…………………………(RGPV 2025)
Q.4The…………………………………………. instrument is used check the Blood Sugar level. (RGPV 2025)
Q.5 The long term use of ………………………………….drugs causes peptic ulcer disease. (RGPV 2025)
State True or False
Q.1 Parkinsons disease is a nervous system disorder that affects the movement. (RGPV 2025)
Q.2 Inadequate dose of a drug is example of Irrational drug use. (RGPV 2025)
Q.3 Credibility is one of the important feature of Standard Treatment Guidelines. (RGPV 2025)
Q.5 COX I and COX 2 are involved in the synthesis of prostaglandins. (RGPV 2025)
Q.6 Malaria is bacterial infection. (RGPV 2025)
Match the columns.
(RGPV 2025)
Column A Column B
Q.1 Supportive a) Chronic Liver Disease
Q.2Clavulanic acid b) Tuberculosis
Q.3Alcohol c) Pharmacotherapy
Q.4Folate Deficiency d) Beta lactamase
Q.5 DOTS e) Megaloblastic anemia
— Best of Luck for Exam —
